Global and China Artificial Intelligence Drug R&D Market Size, Status and Forecast 2023-2027

Report ID: 1014741 | Published Date: Oct 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 AI Platfrom
        1.2.3 Analytics Service
    1.3 Market by Application
        1.3.1 Global Artificial Intelligence Drug R&D Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Drug Discovery
        1.3.3 Precision Medicine
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Artificial Intelligence Drug R&D Market Perspective (2016-2027)
    2.2 Artificial Intelligence Drug R&D Growth Trends by Regions
        2.2.1 Artificial Intelligence Drug R&D Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Artificial Intelligence Drug R&D Historic Market Share by Regions (2016-2021)
        2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Regions (2022-2027)
    2.3 Artificial Intelligence Drug R&D Industry Dynamic
        2.3.1 Artificial Intelligence Drug R&D Market Trends
        2.3.2 Artificial Intelligence Drug R&D Market Drivers
        2.3.3 Artificial Intelligence Drug R&D Market Challenges
        2.3.4 Artificial Intelligence Drug R&D Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Artificial Intelligence Drug R&D Players by Revenue
        3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2016-2021)
        3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2016-2021)
    3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue
    3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio
        3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2020
    3.5 Artificial Intelligence Drug R&D Key Players Head office and Area Served
    3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service
    3.7 Date of Enter into Artificial Intelligence Drug R&D Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Artificial Intelligence Drug R&D Breakdown Data by Type
    4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2016-2021)
    4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2022-2027)

5 Artificial Intelligence Drug R&D Breakdown Data by Application
    5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2016-2021)
    5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Artificial Intelligence Drug R&D Market Size (2016-2027)
    6.2 North America Artificial Intelligence Drug R&D Market Size by Type
        6.2.1 North America Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
        6.2.2 North America Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
        6.2.3 North America Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
    6.3 North America Artificial Intelligence Drug R&D Market Size by Application
        6.3.1 North America Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
        6.3.2 North America Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
        6.3.3 North America Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
    6.4 North America Artificial Intelligence Drug R&D Market Size by Country
        6.4.1 North America Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
        6.4.2 North America Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Artificial Intelligence Drug R&D Market Size (2016-2027)
    7.2 Europe Artificial Intelligence Drug R&D Market Size by Type
        7.2.1 Europe Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
        7.2.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
        7.2.3 Europe Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
    7.3 Europe Artificial Intelligence Drug R&D Market Size by Application
        7.3.1 Europe Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
        7.3.2 Europe Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
        7.3.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
    7.4 Europe Artificial Intelligence Drug R&D Market Size by Country
        7.4.1 Europe Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
        7.4.2 Europe Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size (2016-2027)
    8.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type
        8.2.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
    8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application
        8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
    8.4 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region
        8.4.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Artificial Intelligence Drug R&D Market Size (2016-2027)
    9.2 Latin America Artificial Intelligence Drug R&D Market Size by Type
        9.2.1 Latin America Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
        9.2.2 Latin America Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
        9.2.3 Latin America Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
    9.3 Latin America Artificial Intelligence Drug R&D Market Size by Application
        9.3.1 Latin America Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
        9.3.2 Latin America Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
        9.3.3 Latin America Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
    9.4 Latin America Artificial Intelligence Drug R&D Market Size by Country
        9.4.1 Latin America Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
        9.4.2 Latin America Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size (2016-2027)
    10.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type
        10.2.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
    10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application
        10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
    10.4 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country
        10.4.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 IBM Watson
        11.1.1 IBM Watson Company Details
        11.1.2 IBM Watson Business Overview
        11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction
        11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.1.5 IBM Watson Recent Development
    11.2 BioXel
        11.2.1 BioXel Company Details
        11.2.2 BioXel Business Overview
        11.2.3 BioXel Artificial Intelligence Drug R&D Introduction
        11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.2.5 BioXel Recent Development
    11.3 Insilico Medicine
        11.3.1 Insilico Medicine Company Details
        11.3.2 Insilico Medicine Business Overview
        11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction
        11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.3.5 Insilico Medicine Recent Development
    11.4 Gatehouse Bio
        11.4.1 Gatehouse Bio Company Details
        11.4.2 Gatehouse Bio Business Overview
        11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction
        11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.4.5 Gatehouse Bio Recent Development
    11.5 Google DeepMind
        11.5.1 Google DeepMind Company Details
        11.5.2 Google DeepMind Business Overview
        11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction
        11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.5.5 Google DeepMind Recent Development
    11.6 Genpact Cora
        11.6.1 Genpact Cora Company Details
        11.6.2 Genpact Cora Business Overview
        11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction
        11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.6.5 Genpact Cora Recent Development
    11.7 Cyclica Inc
        11.7.1 Cyclica Inc Company Details
        11.7.2 Cyclica Inc Business Overview
        11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction
        11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.7.5 Cyclica Inc Recent Development
    11.8 QuantumBlack
        11.8.1 QuantumBlack Company Details
        11.8.2 QuantumBlack Business Overview
        11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction
        11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.8.5 QuantumBlack Recent Development
    11.9 Nq Medical
        11.9.1 Nq Medical Company Details
        11.9.2 Nq Medical Business Overview
        11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction
        11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.9.5 Nq Medical Recent Development
    11.10 Phenomic AI
        11.10.1 Phenomic AI Company Details
        11.10.2 Phenomic AI Business Overview
        11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction
        11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.10.5 Phenomic AI Recent Development
    11.11 Palantir Technologies
        11.11.1 Palantir Technologies Company Details
        11.11.2 Palantir Technologies Business Overview
        11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction
        11.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
        11.11.5 Palantir Technologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of AI Platfrom
    Table 3. Key Players of Analytics Service
    Table 4. Global Artificial Intelligence Drug R&D Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Artificial Intelligence Drug R&D Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Artificial Intelligence Drug R&D Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Artificial Intelligence Drug R&D Market Share by Regions (2016-2021)
    Table 8. Global Artificial Intelligence Drug R&D Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Artificial Intelligence Drug R&D Market Share by Regions (2022-2027)
    Table 10. Artificial Intelligence Drug R&D Market Trends
    Table 11. Artificial Intelligence Drug R&D Market Drivers
    Table 12. Artificial Intelligence Drug R&D Market Challenges
    Table 13. Artificial Intelligence Drug R&D Market Restraints
    Table 14. Global Artificial Intelligence Drug R&D Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Artificial Intelligence Drug R&D Market Share by Players (2016-2021)
    Table 16. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Intelligence Drug R&D as of 2020)
    Table 17. Ranking of Global Top Artificial Intelligence Drug R&D Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Artificial Intelligence Drug R&D Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Artificial Intelligence Drug R&D Product Solution and Service
    Table 21. Date of Enter into Artificial Intelligence Drug R&D Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2016-2021)
    Table 25. Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Artificial Intelligence Drug R&D Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2016-2021)
    Table 29. Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. IBM Watson Company Details
    Table 62. IBM Watson Business Overview
    Table 63. IBM Watson Artificial Intelligence Drug R&D Product
    Table 64. IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 65. IBM Watson Recent Development
    Table 66. BioXel Company Details
    Table 67. BioXel Business Overview
    Table 68. BioXel Artificial Intelligence Drug R&D Product
    Table 69. BioXel Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 70. BioXel Recent Development
    Table 71. Insilico Medicine Company Details
    Table 72. Insilico Medicine Business Overview
    Table 73. Insilico Medicine Artificial Intelligence Drug R&D Product
    Table 74. Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 75. Insilico Medicine Recent Development
    Table 76. Gatehouse Bio Company Details
    Table 77. Gatehouse Bio Business Overview
    Table 78. Gatehouse Bio Artificial Intelligence Drug R&D Product
    Table 79. Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 80. Gatehouse Bio Recent Development
    Table 81. Google DeepMind Company Details
    Table 82. Google DeepMind Business Overview
    Table 83. Google DeepMind Artificial Intelligence Drug R&D Product
    Table 84. Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 85. Google DeepMind Recent Development
    Table 86. Genpact Cora Company Details
    Table 87. Genpact Cora Business Overview
    Table 88. Genpact Cora Artificial Intelligence Drug R&D Product
    Table 89. Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 90. Genpact Cora Recent Development
    Table 91. Cyclica Inc Company Details
    Table 92. Cyclica Inc Business Overview
    Table 93. Cyclica Inc Artificial Intelligence Drug R&D Product
    Table 94. Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 95. Cyclica Inc Recent Development
    Table 96. QuantumBlack Company Details
    Table 97. QuantumBlack Business Overview
    Table 98. QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 99. QuantumBlack Recent Development
    Table 100. Nq Medical Company Details
    Table 101. Nq Medical Business Overview
    Table 102. Nq Medical Artificial Intelligence Drug R&D Product
    Table 103. Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 104. Nq Medical Recent Development
    Table 105. Phenomic AI Company Details
    Table 106. Phenomic AI Business Overview
    Table 107. Phenomic AI Artificial Intelligence Drug R&D Product
    Table 108. Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 109. Phenomic AI Recent Development
    Table 110. Palantir Technologies Company Details
    Table 111. Palantir Technologies Business Overview
    Table 112. Palantir Technologies Artificial Intelligence Drug R&D Product
    Table 113. Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
    Table 114. Palantir Technologies Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Artificial Intelligence Drug R&D Market Share by Type: 2020 VS 2027
    Figure 2. AI Platfrom Features
    Figure 3. Analytics Service Features
    Figure 4. Global Artificial Intelligence Drug R&D Market Share by Application: 2020 VS 2027
    Figure 5. Drug Discovery Case Studies
    Figure 6. Precision Medicine Case Studies
    Figure 7. Artificial Intelligence Drug R&D Report Years Considered
    Figure 8. Global Artificial Intelligence Drug R&D Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Artificial Intelligence Drug R&D Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Artificial Intelligence Drug R&D Market Share by Regions: 2020 VS 2027
    Figure 11. Global Artificial Intelligence Drug R&D Market Share by Regions (2022-2027)
    Figure 12. Global Artificial Intelligence Drug R&D Market Share by Players in 2020
    Figure 13. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Intelligence Drug R&D as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2020
    Figure 15. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2016-2021)
    Figure 16. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2022-2027)
    Figure 17. North America Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
    Figure 19. North America Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
    Figure 20. North America Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
    Figure 21. United States Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
    Figure 25. Europe Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
    Figure 26. Europe Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
    Figure 27. Germany Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Region (2016-2027)
    Figure 37. China Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
    Figure 45. Latin America Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
    Figure 46. Latin America Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
    Figure 47. Mexico Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
    Figure 53. Turkey Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. IBM Watson Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 57. BioXel Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 58. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 59. Gatehouse Bio Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 60. Google DeepMind Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 61. Genpact Cora Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 62. Cyclica Inc Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 63. QuantumBlack Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 64. Nq Medical Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 65. Phenomic AI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 66. Palantir Technologies Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
IBM Watson
BioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
Palantir Technologies
Frequently Asked Questions
Artificial Intelligence Drug R&D report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Artificial Intelligence Drug R&D report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Artificial Intelligence Drug R&D report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Galidesivir

Global Galidesivir Scope and Market Size
Galidesivir market is segmented by company ... Read More